Abstract-The burden of hypertension in Sub-Saharan Africa has been increasing over the past few decades. However, a large proportion of the population with hypertension remains undiagnosed, untreated, or inadequately treated, contributing to the rising burden of cardiovascular disease in the region. We conducted a systematic review and meta-analysis to assess the recent burden of hypertension in Sub-Saharan Africa, based on studies published between 2000 and 2013. We pooled data from 33 surveys involving over 110 414 participants of mean age 40 years. Hypertension prevalence varied widely across the studies (range 15%-70%), partly because of differences in participant mean ages (31-76 years). The predicted prevalence of hypertension at mean participant ages of 30, 40, 50, and 60 years were 16%, 26%, 35%, and 44%, respectively, with a pooled prevalence of 30% (95% confidence interval, 27%-34%). Of those with hypertension, only between 7% and 56% (pooled prevalence: 27%; 95% confidence interval, 23%-31%) were aware of their hypertensive status before the surveys. Overall, 18% (95% confidence interval, 14%-22%) of individuals with hypertension were receiving treatment across the studies, and only 7% (95% confidence interval, 5%-8%) had controlled blood pressure. This review found a high prevalence of hypertension, as well as low percentage of hypertension awareness, treatment, and control in Sub-Saharan Africa, highlighting the need for implementation of timely and appropriate strategies for diagnosis, control, and prevention. (Hypertension.
H ypertension is the largest contributor to global burden of disease, accounting for 7% of global disability adjusted life years. 1 The burden of hypertension has been increasing continuously in Sub-Saharan Africa (SSA) over the past few decades. 1, 2 This has potentially severe consequences in the region as a large proportion of those with hypertension probably remain undiagnosed, untreated, or inadequately treated, hence are at high risk for morbidity and mortality from potentially preventable complications of hypertension such as stroke and heart disease. 3 Hypertension is an important contributor to the rising burden of cardiovascular disease in SSA, which is expected to nearly double by the year 2030. 4, 5 Tackling the rising burden of hypertension in SSA is most likely a cost-effective approach to curbing the societal and economic impact of cardiovascular disease in the region. Such an approach would involve concerted efforts to improve early detection of hypertension, increase hypertension awareness in the community, and improve access to affordable healthcare for those with the condition. Although there have been individual reports on prevalence of hypertension awareness, treatment, and control in SSA, the data have not been appropriately synthesized to date. We conducted a systematic review and meta-analysis of the extant literature on the burden of undiagnosed, untreated, and uncontrolled hypertension in SSA, to help quantify the magnitude of the problem in the region and highlight the need for relevant and appropriate control and prevention strategies.
Methods

Search Strategy
To provide the most current review of the epidemiology of hypertension in SSA, we searched the PubMed and EMBASE databases for recently published (January 2000 to December 2013) articles on the epidemiology of hypertension in SSA. We also searched Web of Knowledge and scanned reference lists of relevant articles. We used the following inclusion criteria to select studies: participants living in SSA, population-based design, sample size >1000, age of participants >15 years, and study reporting on prevalence of hypertension as well as on prevalence of hypertension awareness, treatment, and/or control. February 2015
Where multiple surveys were conducted in different countries or at different calendar years and reported within the same article, each survey was counted as a separate study. Accordingly, 33 original studies meeting the inclusion criteria were included in this review (see Tables S1-S3 and Figure S1 in the online-only Data Supplement for further details of search strategy). To minimize further the effect of any publication bias, we searched for unpublished data in the World Health Organization (WHO) InfoBase. We identified 20 studies conducted using the WHO STEPwise approach to surveillance (STEPS) methods, of which only 5 were published in peer-reviewed journals. We used the unpublished data for ancillary analyses.
Data Extraction
We extracted the following information from the publications: location, study design/size, years of survey, response rate, mean age of participants (or median, or range, whichever was the only available summary measure of the age of participants), proportion of females, blood pressure measurement method, as well as estimates of prevalence of hypertension (overall and within strata of sex and locality), hypertension awareness, treatment, and control. Where overall mean or median age was not reported, we used information on number of participants by age strata, where available, to approximate mean age of the study participants. Hypertension awareness was defined as self-report of prior diagnosis of high blood pressure by a health professional. Hypertension treatment was defined as self-reported use of a recognized antihypertensive medication for management of high blood pressure at time of survey (or within a specific time period of the survey). Hypertension control was defined as having a blood pressure <140/90 mm Hg at time of survey among those receiving antihypertensive medications. The prevalence of hypertension awareness, treatment, and control were estimated as percentages of all the participants with a diagnosis of hypertension (both known and screen-detected); where necessary, the denominators were changed to achieve consistency across studies. 
Statistical Analysis
Standard errors for the study-specific prevalence estimates were determined from the point estimate and the appropriate denominators, assuming a binomial distribution. To obtain an overall summary estimate of the prevalence across studies, we pooled the study-specific estimates using a random-effects meta-analysis model. 36 We also performed a fixedeffect meta-analysis for comparison. Between-study heterogeneity was assessed using the Cochran Q and I 2 statistics. 37 The I 2 statistic estimates the percentage of total variation across studies that is due to true betweenstudy differences rather than chance. 38 We explored sources of heterogeneity by comparing hypertension prevalence between subgroups defined by study-level characteristics. We assessed the presence of publication bias using funnel plots and the Egger test 39 and by comparing the pooled prevalence between larger and smaller studies. To assess any undue influence from studies with extreme prevalence estimates, we conducted sensitivity analyses that first stabilized the variance of the study-specific prevalence using the double arcsine transformation before pooling using the random-effects meta-analysis model. 40 All analyses were performed using Stata software (Stata Corp v13, TX).
Results
Description of Studies
The characteristics of the 33 cross-sectional studies included in this review are summarized in the Table and Table S4 . The size of the studies ranged from 1013 to 10 457 participants, with a total of 110 414 participants. The average age of participants ranged from 31 to 76 years (weighted mean=40 years), while the proportion of women ranged from 39% to 68% (weighted mean=56%). Fourteen studies were conducted in urban localities, 9 in rural localities, and the rest in both rural and urban settings. Thirteen surveys were conducted using the WHO STEPS approach, whereas 2 studies were conducted as part of the WHO Study on Global Ageing and Adult Health (SAGE). The response rate ranged from 53% to 99% across studies. The design features and hypertension assessment methods of included studies are provided in Table S5 .
Prevalence of Hypertension, Awareness, and Control
The prevalence of hypertension ranged from 14.7% , South Africa; mean age of participants, 38 years) to 69.9% (Dewhurst MJ, 2013 ; mean age of participants, 76 years). The median prevalence was 29%, and the randomeffects model combined prevalence across the 33 studies was 30% (95% confidence interval [CI], 27%-34%; Figure 1 ). Across studies, the prevalence of hypertension increased with age ( Figure S2 ) while it was broadly comparable between rural and urban areas ( Figures S3-S5 ), or between females and males ( Figure S6 ). Prevalence of hypertension across 33 African studies. Black boxes represent the effect estimates (prevalence) and the horizontal bars about are for the 95% confidence intervals (CIs). The size of the boxes is proportional to the inverse variance. The diamond is for the pooled effect estimate and 95% CI, and the dotted vertical line centered on the diamond has been added to assist visual interpretation. Effect estimates (provided as proportions) must be multiplied by 100 to obtain the prevalence. by guest on January 27, 2018 http://hyper.ahajournals.org/
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Only a small proportion of the people with hypertension were aware of their hypertensive status before the surveys (median, 22.5%; pooled prevalence, 27% [95% CI, 23%-31%], Figure 2 ). Between 2.7% (Oladapo O, 2010, Nigeria) and 59.4% (Bovet P, 2006 , Seychelles) of the hypertensive people (median, 13.6%; pooled prevalence, 18% [95% CI, 14%-22%], Figure 3 ) were receiving treatment with antihypertensive medications; between 0.4% (Edwards R, 1999, Tanzania) and 39.2% (Bovet P, 2006 , Seychelles) had their blood pressure levels under control (median, 3.6%; pooled prevalence, 7% [95% CI, 5%-8%], Figure 4) . Sensitivity analyses using a fixed-effect meta-analysis model yielded similar results; in addition, applying the variance stabilizing arcsine transformation before pooling the study-specific estimates had only trivial effects on the overall result (data available from authors on request). Ancillary analyses were performed using data obtained from the WHO InfoBase on 20 STEPS surveys (Table S6) ; of which five surveys had been published in peer-reviewed journals and were already included the current meta-analysis while the rest were not. Pooled analyses of these 20 surveys separately and then combined with the studies already in the meta-analysis yielded an overall prevalence of 30% (95% CI, 27%-33%) and 31% (95% CI, 28%-33%), respectively ( Figures S7 and S8 ).
Sources of Heterogeneity
There was substantial heterogeneity across the 33 studies in terms of hypertension prevalence, awareness, treatment, and control (I 2 >98%, P<0.0001 for each category). Of the studylevel characteristics, mean age of participants partly explained the between-study heterogeneity ( Figures S2 and S9 ). There was also a trend for study-specific prevalence to vary by study design, with the WHO SAGE surveys reporting significantly higher prevalence (P=0.027). Together mean age of participants and study design explained 49% of the between-study heterogeneity. Hypertension prevalence was not different between subgroups defined by other study-level characteristics such as publication year, sample size, or sex distribution ( Figure S9 ). The predicted prevalence of hypertension for studies comprising of 50% females and mean age of participants of 30, 40, 50 and 60 years were 16%, 26%, 35%, and 44%, respectively. Additional variables explored in relation to heterogeneity were body weight and education levels of participants, but data on these were only available in a small Figure 2 . Prevalence of hypertension awareness among people with hypertension across African studies. Black boxes represent the effect estimates (prevalence) and the horizontal bars about are for the 95% confidence intervals (CIs). The size of the boxes is proportional to the inverse variance. The diamond is for the pooled effect estimate and 95% CI, and the dotted vertical line centered on the diamond has been added to assist visual interpretation. Effect estimates (provided as proportions) must be multiplied by 100 to obtain the prevalence. by guest on January 27, 2018 http://hyper.ahajournals.org/ Downloaded from subset of the studies. Hypertension prevalence was positively correlated with the proportion of participants who were overweight or obese but not with the proportion of participants who had a postprimary or higher level of education ( Figures  S10 and S11) .
The between-study heterogeneity in prevalence of hypertension awareness was partially explained by study population (with studies on white collar workers reporting higher proportion of hypertension awareness) and by proportion of participants from rural localities (with studies having larger proportion of participants from rural localities reporting lower prevalence of hypertension awareness; Figure S12 ). Together these 2 characteristics explained 53% of the between-study heterogeneity. Similarly, between-study heterogeneity in proportions receiving hypertension treatment was partially explained by the proportion of participants from rural localities, with studies having larger proportion of participants from rural localities reporting lower proportion receiving hypertension treatment (which accounted for 11% of the heterogeneity) ( Figure S13 ). Between-study heterogeneity in proportion achieving hypertension control was not explained by available study-level characteristics ( Figure S14 ).
There was some evidence of publication bias across studies reporting on hypertension prevalence, with the Egger test for bias giving a P-value of 0.003 ( Figure S15) ; however, smaller studies were not more likely to report more extreme results compared with larger studies (P-value, 0.21; Figure S9 ). In addition, publication bias test performed as sensitivity analysis, after arcsine transformation of study-specific estimates, was not statistically significant (P-value, 0.31, data available on request). Egger test for bias P-value was significant for studies reporting on prevalence of hypertension awareness, treatment, and control (all P<0.01, Figures S16-18 ). It is of note, however, that awareness, treatment, or control were not the main outcomes of most of the included studies.
Discussion
In the present systematic review of data from 33 surveys involving over 110 000 participants, we found a pooled prevalence of hypertension of 30% in SSA. Notably, only 27% of people with hypertension were aware of their hypertensive status before the surveys on average; only 18% were receiving treatment on average, and only ≈7% had controlled blood pressure. Our findings supplement previous studies including systematic reviews on hypertension in SSA, 2, 3, 41, 42 by providing an updated and comprehensive synthesis of data on the extent of underdiagnosed and undertreated hypertension in the region. Our findings contrast with substantially much higher prevalence of hypertension awareness, treatment, and control reported from other regions of the world, including highincome 43 and other low-and middle-income countries. 44 As hypertension is a major risk factor for cerebrovascular disease, ischemic heart disease, heart failure, and chronic kidney disease, it contributes to a significant proportion of the increasing cardiovascular disease burden in SSA. [45] [46] [47] Despite the endorsement of the identification and control of blood pressure as a priority by many national and global organizations, 45, 48 and the availability of inexpensive and effective medications, difficulties in implementation of screening programs, and lack of access to affordable healthcare pose challenge to control of hypertension in SSA. Other barriers, including limited knowledge about hypertension among health professionals and patients, and poor adherence to medication among individuals started on treatment, contribute to poor control of hypertension. 49 The scarcity of infrastructure to manage people with hypertension and the noncomprehensive nature of public health policies to control hypertension in the region are additional challenges. 4 There is a need for local policy-makers to incorporate relevant public health and primary care strategies of prevention and control that account for the extent of unrecognized and suboptimally controlled hypertension. The aforementioned challenges are illustrated in a 1-year follow-up study of newly diagnosed hypertensive patients in South Africa, which showed that, despite referral, 63% had uncontrolled hypertension and that 27% claimed to be unaware of their hypertension. 2 Models of care that include task shifting from physician to other health workers (eg, nurses) may potentially lead to better results by circumventing the lack of physicians. The effectiveness of such models of care has been demonstrated in some African countries.
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The strengths and limitations of the current review merit some consideration. First, we used a comprehensive search strategy and adhered to prespecified inclusion and exclusion criteria. Second, we used a stringent and reasonably large sample size criterion for including studies in this review (>1000 participants), thus increasing the robustness of our results. Third, the included studies were population based with a fairly high participation rate, and most studies reported >75% participation, which increases the representativeness of the studies. Finally, our study is quantitative and highlights the large magnitude of undiagnosed, untreated, and uncontrolled hypertension across SSA. Regarding limitations, there was substantial heterogeneity across the studies, only partially explained by available study-level characteristics. This may in part be because of between-study differences in methodology and population structures; but it may also represent true regional differences in disease burden and access to healthcare. There is need for standardizing methods for assessing hypertension prevalence across studies in SSA, such as universal use of the WHO STEPS approach in surveys, and reporting of age-and sex-standardized estimates. Second, information on the use of antihypertensive medications was lacking from most studies. Third, there was some evidence of publication bias. However, the pooled estimates from larger and smaller studies were comparable, and statistical test for publication bias on arcsine transformed estimates was not significant, indicating that the magnitude of the bias was likely limited.
Perspectives
One key unaddressed question is that of the effective use of medications for controlling of hypertension in the SSA populations and of their appropriateness for these populations. As the vast majority of trials of hypertension have generally not included participants of SSA populations, current treatment guidelines are extrapolations of findings of studies among blacks living in Western countries, which may not necessarily generalize to SSA populations. In addition, studies are needed to assess progress made in tackling hypertension SSA, through investigations of time trends in hypertension frequency, treatment, and outcomes, using repeated surveys with comparable methodologies over time, such as those used in the WHO MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) project. 51 Supplementation of hypertension detection and control efforts by measures of prevention through addressing behavioural risk factors, such as excessive salt intake and physical inactivity, is also warranted. Furthermore, creation of control programs implemented through primary healthcare systems and their integration in infrastructures created for existing programs, such as HIV/AIDS program, 5 ,51,52 can help create an affordable and sustainable way to tackle hypertension in low-income countries. 5, 46 Indeed, lessons are to be learnt from the approaches used to manage HIV/AIDS in SSA, 53 where laudable initiatives championed by governments and foundations have transformed lives and restored hope to millions of people. A similar concerted international effort toward detection and prevention of chronic diseases, including hypertension, is needed now-before the looming epidemic takes hold.
In summary, we found a high prevalence of hypertension, as well as a low prevalence of hypertension awareness, treatment, and control in SSA, highlighting the need for concerted action to avert the high health and economic burden that the disease entails. What Is New?
• This study provides summary and updated data on the burden of undiagnosed, untreated, and inadequately treated hypertension in Sub-Saharan Africa.
• The pooled prevalence of hypertension in the region was 30%; on average, 73% of the hypertensive individuals were unaware of their hypertensive status; only18% were receiving treatment; and only ≈7% had controlled blood pressure.
What Is Relevant?
• These findings indicate that substantial efforts are needed to achieve effective prevention and control of hypertension in the region.
Summary
There is a high prevalence of hypertension, as well as low percentage of hypertension awareness, treatment, and control in SubSaharan Africa, highlighting the need for implementation of timely and appropriate strategies for diagnosis, control, and prevention.
1 SUPPLEMENTARY 
Table S1 -Expanded Search Strategy section (Methods)
To provide the most current review of the epidemiology of hypertension in SSA, we conducted a primary literature search in PubMed and EMBASE databases for recently published articles on the epidemiology of hypertension in SSA, from January 2000 to December 2013. We used a combination of free text and Medical Subject Heading (MeSH) terms related to "Hypertension", "Sub-Saharan Africa", and "Prevalence" (see S2-S4 details of search terms used). We also searched the databases of Web of Knowledge and scanned the references lists of relevant systematic reviews. The PubMed and EMBASE searches retrieved 2105 articles after removal of duplicates, which were reviewed for relevance using their titles and abstracts. Accordingly, 75 potentially relevant articles were selected for further assessment based on the following inclusion criteria: participants living in SSA, population-based design, sample size >1000, age of participants > 15 years, and study reporting on prevalence of hypertension, awareness, treatment, and/or control. Where studies were reported more than once, we used the article with the largest number of participants. Where multiple surveys were conducted in different countries or at different calendar years and reported within the same article, each survey was counted as a separate study. Accordingly, 31 original studies identified from PubMed met the inclusion criteria and a further 2 studies were identified from the Web of Knowledge search and scanning of reference lists; yielding a total of 33 studies (1-30) included in this review (see S2-S5 for details of search strategy, flow diagram). To further minimize the effect of any publication bias, we searched for unpublished data in the World Health Organization (WHO) InfoBase. We identified 20 WHO STEPS surveys in SSA, of which only five were published in peer reviewed journals. We use the unpublished data for ancillary analyses. 
Proportion of Hypertension control
Figure S15 -Funnel plot of 33 studies of hypertension prevalence Funnel plot is constructed by plotting the study specific prevalence estimates against the standard errors of the estimates. Each dot represents a single study. In the absence of bias, the dots are expected to spread symmetrically in a funnel shape. P-value is test for significance of publication bias Figure S15 
